We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
This Dividend Aristocrat Posted Record Quarterly Results
Read MoreHide Full Article
Everybody loves dividends, as they provide a passive income stream, limit drawdowns in other positions, and provide more than one way to profit from an investment.
And when considering dividend-paying stocks, those with a history of boosting their payout are prime considerations, reflecting their commitment to increasingly rewarding shareholders.
And when it comes to a consistent history of increased payouts, look no further than the Dividend Aristocrats.
Johnson & Johnson (JNJ - Free Report) fits the criteria nicely.
Johnson & Johnson Outperforms
Johnson & Johnson shares have quietly delivered a huge gain in 2026 so far, up more than 25%. The gain has similarly shown strong outperformance relative to the S&P 500, with recent results driving positive momentum post-earnings.
Sales of $25.3 billion reflected a new quarterly record for the company, growing by a solid 6.6% year-over-year. It also increased both its current fiscal year sales and adjusted EPS guidance, with JNJ now on track to meet its 2026 target of more than $100 billion in annual revenue for the first time in its history.
Below is a chart illustrating the company’s dividends/share on a quarterly basis.
Image Source: Zacks Investment Research
Bottom Line
Everybody loves dividends, essentially investors’ form of payday. They can help limit drawdowns in other positions and provide an income stream, two key traits that all market participants enjoy.
And for those seeking companies with a consistent history of steady payouts, Johnson & Johnson (JNJ - Free Report) fits the criteria.
Image: Bigstock
This Dividend Aristocrat Posted Record Quarterly Results
Everybody loves dividends, as they provide a passive income stream, limit drawdowns in other positions, and provide more than one way to profit from an investment.
And when considering dividend-paying stocks, those with a history of boosting their payout are prime considerations, reflecting their commitment to increasingly rewarding shareholders.
And when it comes to a consistent history of increased payouts, look no further than the Dividend Aristocrats.
Johnson & Johnson (JNJ - Free Report) fits the criteria nicely.
Johnson & Johnson Outperforms
Johnson & Johnson shares have quietly delivered a huge gain in 2026 so far, up more than 25%. The gain has similarly shown strong outperformance relative to the S&P 500, with recent results driving positive momentum post-earnings.
Sales of $25.3 billion reflected a new quarterly record for the company, growing by a solid 6.6% year-over-year. It also increased both its current fiscal year sales and adjusted EPS guidance, with JNJ now on track to meet its 2026 target of more than $100 billion in annual revenue for the first time in its history.
Below is a chart illustrating the company’s dividends/share on a quarterly basis.
Image Source: Zacks Investment Research
Bottom Line
Everybody loves dividends, essentially investors’ form of payday. They can help limit drawdowns in other positions and provide an income stream, two key traits that all market participants enjoy.
And for those seeking companies with a consistent history of steady payouts, Johnson & Johnson (JNJ - Free Report) fits the criteria.